Press Releases
NovaBay Pharmaceuticals Reports Activity of Aganocide NVC-422 Against Deadly...
NovaBay Pharmaceuticals, a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces that in tests conducted at...
Press Releases
Lundbeck phase III studies confirm nalmefene as efficacious and...
H. Lundbeck A/S (Lundbeck) announced the completion of two out of three pivotal studies in the phase III clinical programme for nalmefene in alcohol dependence...
Press Releases
Personalised Medicine and Diagnostics Europe 2011
Innovate in an era of cost-effectiveness: Realise the value of personalised medicine Discover how to strengthen your drug pipeline with companion diagnostics How to...
Press Releases
King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New...
King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. announced that King has resubmitted a New Drug Application (NDA) for REMOXY (oxycodone) to the U.S. Food and...
Press Releases
Sanofi-aventis Acquires from Ascendis Pharma Worldwide Rights on Drug-Delivery
Sanofi-aventis and Ascendis Pharma (Ascendis) announced a global licensing and patent transfer agreement on Ascendis’ proprietary TransCon Linker and Hydrogel carrier technology, which allows for...
Press Releases
Bristol-Myers Squibb Company and Pfizer Inc.announced that the ADVANCE-3...
Bristol-Myers Squibb Company and Pfizer Inc.announced that the ADVANCE-3 study results, published in The New England Journal of Medicine, showed apixaban was statistically superior to...
Press Releases
Novartis drug Tasigna approved in Japan for treatment of...
Novartis has received approval from Japan's Ministry of Health, Labour and Welfare to offer Tasigna® (nilotinib) as a treatment for adult patients with newly diagnosed...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.